DNLI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Denali Therapeutics Inc

Watchlist Manager

Watchlist

Price: 20.81 USD -3.66%

Market Cap: $3.3B

	Denali Therapeutics Inc NASDAQ:DNLI	US
	BREMER LAGERHAUS-GESELLSCHAFT AG von 1877 F:BLH	DE
S	Synnex (Thailand) PCL SET:SYNEX	TH
B	Banca Mediolanum SpA SWB:ME1	IT
S	Shiseido Co Ltd DUS:SHD	JP
N	Nimy Resources Ltd ASX:NIM	AU
W	Wedge Holdings Co Ltd TSE:2388	JP
R	Refrigeration Electrical Engineering Corp VN:REE	VN
	Fortuna Mining Corp TSX:FVI	CA
U	Ultralife Corp F:ULB	US
H	HSBC Holdings PLC XMUN:HBC1	UK
	Community Healthcare Trust Inc F:4U9	US
	Jeudan A/S F:0AZ	DK

Profitability Summary

Denali Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Sustainable 3Y Average Gross Margin

19%

Negative Operating Margin

-15 058%

Negative 3Y Average Operating Margin

-10 673%

Declining Operating Margin

-48% > -15 058%

Negative Net Margin

-14 191%

Negative 3Y Average Net Margin

-9 320%

Declining Net Margin

-37% > -14 191%

Negative Free Cash Flow Margin

-12 937%

Negative 3Y Average Free Cash Flow Margin

-8 848%

Declining Free Cash Flow Margin

-94% > -12 937%

Negative ROE

-55%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-134%

Declining ROIC

-101% > -157%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.